 
                                David M. Berman
@virchow
Evolving to DocterBeman on that celestial azure app. Urologic pathologist, biomarker discovery scientist, and Dept Head. Editor-in-Chief for @LIjournal He/him
ID: 16156716
http://goo.gl/mwQZ1W 06-09-2008 13:51:36
3,3K Tweet
3,3K Takipçi
4,4K Takip Edilen
 
        Fellowship position available for 2025-26 in Surgical Pathology, with focus on Cutaneous Pathology and Head & Neck Pathology Penn Path & Lab Medicine Surgical Pathology Fellowship | University of Pennsylvania | Pathology and Laboratory Medicine (upenn.edu) #pathology
 
        ModPath CHAT episode coming soon! Great discussion on "Pathologist-Driven Reflex Somatic Tumor DDR Testing in Localized Prostate Cancer" with Susan Prendeville, MD and Shamini Selvarajah, PhD from University of Toronto.Association for Molecular Pathology USCAP Modern Pathology Penn Path & Lab Medicine
 
                        
                    
                    
                    
                 
         
        Prostate cancer invading into fat in trans-urethral resections of the prostate (TURP) does NOT necessarily = extra-prostatic extension- see below 👇👇 Grateful to be included in this work Ankur Sangoi @stanfordpath #GUpath #PathTwitter
 
                        
                    
                    
                    
                 
        Still accepting positions for 2025-26 and one spot available for 2026-27 in Selective Surgical Pathology with subspecialty focus. Penn Path & Lab Medicine #SPFellowship #Pathology
 
        POU4F3 is a Sensitive and Specific Marker of Merkel Cell Carcinoma - ScienceDirect cc: USCAP George J. Netto MD Modern Pathology sciencedirect.com/science/articl…
 
        Congratulations Lillian Siu
 
         
         
         
         
         
        Excited to share my PhD research in Cancer Research and at #AACR2025 which elucidates the non-receptor tyrosine kinase Fes as a novel innate immune checkpoint whose deletion enhances innate immunity and sensitizes ICI-resistant tumours to anti-PD1 blockade! Sinclair Cancer Research Institute Queen's Health Sciences
 
         
         
         
                         
                         
                         
                         
                         
         
                        